European regulators have begun a risk-benefit review of Biogen Idec’s multiple sclerosis drug Tysabri, which has been linked to 23 …

TRB Chemedica UK has appointed Anna ‘Lito’ Michala as sales executive for Scotland and the North of England.Lito joins the …
European regulators have approved an expanded version of Novartis’ high blood pressure treatment Exforge.Exforge was first approved in Europe in …

Merck has turned in stable figures for the third quarter of the year, with global sales up 2% on the …

Bayer Schering Pharma has expanded its InBed erectile dysfunction awareness campaign, adding to YouTube 60 short videos that take a …
Pfizer's third-quarter results have seen it reap the benefit of its cost-cutting measures, including a reduction in headcount of around …

We remember most clearly the leaders that have inspired us and shared their wisdom, and we absorb key truths from …
PharmaSwiss is planning to build a brand new manufacturing unit in Belgrade, Serbia, to allow it to carry out end-to-end …
A 'liver czar' is to be brought into the Department of Health to develop and oversee an effective strategy to …
More than 100,000 products and 25 retail pharmacies in Stockholm will take part in a two-month anti-counterfeiting project run by …

DNA Healthcare Advertising has appointed Jamie Hooper as an account manager.In his new role Jamie will work on a number …
Barbara Britten has joined Pharmexx UK as a business developement director.She most recently worked at Actelion, where she held the …
The UK's swine flu vaccination programme began today with NHS hospitals offering the jabs to frontline healthcare workers and patients …
Lonza said it has elected not to proceed with a $460 million bid to buy Canadian contract manufacturing and development …
Syntaxin, a biopharmaceutical company developing novel biologic drugs that control cell secretion, has appointed Andrew Sandham executive chairman.This follows the …

French genome engineering company Cellectis has appointed Dr Sylvie Delassus senior vice president communications and a member of its executive …

Contract research organisation Quintiles has launched a website for people considering participating in clinical trials. The company hopes Clinicalresearch.com will …
GlaxoSmithKline’s Votrient has been approved in the US by the FDA to treat the most common form of kidney cancer.This …